Source: Pharmaceutical Processing

Vybion: Vybion Huntington's Disease Drug Patent Receives Track I Status

NewsThe patent application covers several neurodegenerative diseases in addition to Huntington's Disease, including Spinal Cerebellar Ataxia, Spinal Muscular Atrophy, and Alzheimer's.Contributed Author: Vybion, Inc.Topics: Drug Development

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more